Menu
← Oncology Approval Tracker
FDA DECISION ·
Jemperli
dostarlimab-gxly · GlaxoSmithKline
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
For adults with recurrent or advanced dMMR endometrial cancer after progression during or after platinum therapy, when curative surgery or radiation is unsuitable.
LAMPGEN ANALYSIS
Why it matters
The action converted the dMMR endometrial monotherapy use to traditional approval.
What research teams should watch
Verify the mismatch repair result, progression after platinum and eligibility for curative local treatment.
PRIMARY RECORDS